Relationship between peripheral-blood immuno-inflammatory markers, radiotherapy efficacy, and 1-year overall survival rate among patients with stage III non-small cell lung cancer
International Journal of Radiation Research · 01.01.2026 · 24 (1) · 151-157
DOI: 10.66224/ijrr.24.1.23 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Research, online erschienen am 01.01.2026. Verfasst von T. Li Li und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, T. L., Han, B., Dong, Q., & Ji, D. (2026). Relationship between peripheral-blood immuno-inflammatory markers, radiotherapy efficacy, and 1-year overall survival rate among patients with stage III non-small cell lung cancer. International Journal of Radiation Research, 24(1), 151-157. https://doi.org/10.66224/ijrr.24.1.23
Vancouver
Li TL, Han B, Dong Q, Ji D. Relationship between peripheral-blood immuno-inflammatory markers, radiotherapy efficacy, and 1-year overall survival rate among patients with stage III non-small cell lung cancer. International Journal of Radiation Research. 2026;24(1):151-157. doi:10.66224/ijrr.24.1.23
BibTeX
@article{Li2026,
author = {Li, T. Li and Han, B. and Dong, Q. and Ji, D.},
title = {Relationship between peripheral-blood immuno-inflammatory markers, radiotherapy efficacy, and 1-year overall survival rate among patients with stage III non-small cell lung cancer},
journal = {International Journal of Radiation Research},
year = {2026},
volume = {24},
number = {1},
pages = {151--157},
doi = {10.66224/ijrr.24.1.23}
}
EUVIMED